These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 2512688
1. Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells. Kaji T, Itoh F, Hayakawa Y, Oguma Y, Sakuragawa N. Thromb Res; 1989 Oct 01; 56(1):99-107. PubMed ID: 2512688 [Abstract] [Full Text] [Related]
3. Heparin enhances thrombin-stimulated prostaglandin I2 production by cultured endothelial cells. Itoh F, Kaji T, Hayakawa Y, Oguma Y, Sakuragawa N. Thromb Res; 1990 Feb 15; 57(4):481-8. PubMed ID: 2158150 [Abstract] [Full Text] [Related]
4. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate. Kaji T, Ejiri N, Hayakawa Y, Hayashi T, Sakuragawa N. Thromb Res; 1990 Jul 15; 59(2):269-77. PubMed ID: 2122537 [Abstract] [Full Text] [Related]
5. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells. McGuire EA, Tollefsen DM. J Biol Chem; 1987 Jan 05; 262(1):169-75. PubMed ID: 3793724 [Abstract] [Full Text] [Related]
6. Low molecular weight heparin enhances prostacyclin production by cultured human endothelial cells. Kaji T, Yamamoto C, Sakamoto M. Chem Pharm Bull (Tokyo); 1991 Dec 05; 39(12):3368-9. PubMed ID: 1667624 [Abstract] [Full Text] [Related]
8. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall. Pasche B, Swedenborg J, Frebelius S, Olsson P. Thromb Res; 1991 Jun 01; 62(5):409-19. PubMed ID: 1896960 [Abstract] [Full Text] [Related]
9. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells. Horie S, Ishii H, Kazama M. Thromb Res; 1990 Sep 15; 59(6):895-904. PubMed ID: 2175954 [Abstract] [Full Text] [Related]
10. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II. Blinder MA, Tollefsen DM. J Biol Chem; 1990 Jan 05; 265(1):286-91. PubMed ID: 2104620 [Abstract] [Full Text] [Related]
13. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate. Ben Mansour M, Dhahri M, Vénisse L, Jandrot-Perrus M, Chaubet F, Maaroufi RM. Thromb Res; 2009 Apr 05; 123(6):902-8. PubMed ID: 19046760 [Abstract] [Full Text] [Related]
14. Activation of heparin cofactor II by dermatan sulfate. Tollefsen DM, Pestka CA, Monafo WJ. J Biol Chem; 1983 Jun 10; 258(11):6713-6. PubMed ID: 6687888 [Abstract] [Full Text] [Related]
15. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Koyama T, Parkinson JF, Sié P, Bang NU, Müller-Berghaus G, Preissner KT. Eur J Biochem; 1991 Jun 15; 198(3):563-70. PubMed ID: 1646716 [Abstract] [Full Text] [Related]
16. The role of heparin cofactor II in the modulation of hemostasis. Salem HH, Thompson EA. Dev Biol Stand; 1987 Jun 15; 67():67-72. PubMed ID: 3301469 [Abstract] [Full Text] [Related]
19. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate. Sié P, Fernandez F, Caranobe C, Gabaig AM, Boneu B. Thromb Res; 1984 Jul 15; 35(2):231-6. PubMed ID: 6206589 [No Abstract] [Full Text] [Related]
20. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate. Cosmi B, Agnelli G, Young E, Hirsh J, Weitz J. Thromb Haemost; 1993 Sep 01; 70(3):443-7. PubMed ID: 8259546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]